hjärtmätare hjärtmonitor

Follow your heart with Coala

Coala is a unique, prize-winning, Swedish innovation for daily monitoring and analysis of your heart. A patented medical device solution to aid the early detection of heart diseases such as atrial fibrillation, and with direct connection to caregivers. It's a ground-breaking digital service open for everyone based on many years of research and development in Sweden. Order from us or visit your local LloydsPharmacy retailer.

Use the Coala as part of your everyday life to follow your heart. Simply keep it in your handbag or just keep it on your night stand. Your heart deserves to be checked every day. No sticky electrodes to stick on, nothing that requires surgery, just smart technology for your health security. Analysis takes a minute and you get the results directly in your smart phone.

It's all about prevention, detecting early signs of heart disease, alleviating worries and reducing burden on healthcare. 

 

There is nothing like it, simply Swedish medical and technological perfection.

The Coala is a CE-approved Class IIa medical device system approved for home use. It's based on advanced technology that is simple and very easy to use. A wireless and cloud-based service that allows anyone, anywhere to quickly check their heart. The Coala is available in several versions; both for consumers and caregivers.

It's all designed, developed, produced and validated in Sweden. Based on more than 10 years of research and development. A unique digital health product and service for cardiac analysis and remote, cloud based monitoring capabilities. It's the first consumer targeted system to record and analyze the heart’s ECG and sound with smart algorithms and integration to caregivers.

Check out the three minute video for an overview.

 
Produktbild_3_01_02_low_kv.jpg

Records your ECG and heart sound simultaneously, and analyzes for 11 different arrhythmias in real-time.

The Coala Heart Monitor is an end user centered medical device service for screening of heart’s electrical and mechanical characteristics.

The Coala enables simultaneous ECG and digital heart sound recordings, with advanced, smart ECG algorithms developed in collaboration with the Karolinska Hospital and Lund Universities, providing near real time results in the Coala App. Designed to enable early detection of heart diseases such as atrial fibrillation, with results within a minute. 

The results of the analysis are presented in the Coala App and all the data is stored securely in the cloud and available easy for caregivers to access through the Coala Care portal. It's the ideal e-health system to digitize cardiac care, improve preventive detection and identify heart disease in time.

The Coala Heart Monitor Pro is intended for caregivers to perform multi-patient arrhythmia assessments and smart digital remote monitoring. Simply telemedicine 2.0.

 

It's not just a device for detecting Atrial Fibrillation (AFIB), it's a complete digital service.

The Coala Heart Monitor is so much more than a device that detects AFIB, it's a complete solution based for remote monitoring. The Coala records the heart sound and performs high performance ECG recordings. It takes just a minute and it analyzes and screens for 11 different cardiac pathologies. This includes AFIB, PVC, PAC, AV block II etc. 

It's a subscription based service that can be connected to a caregiver of your choice. Coala Premium subscribers are integrated to HeartCareLine™ (Hjärtupplysningen™) a health care provider (currently only available in Sweden) that offers instant and smart health care advice via phone.

Use the Coala whenever and whereever you want, you're in control.

 

 

No sticky, degrading patches and no separate electrodes. It's all integrated and intelligent. 

Inside the Coala is unique, patented technology based on more than 10 years of research and development. The Coala consists of a unique high performance membrane that records and digitizes the sounds of your heart, and with three smart electrodes that record and analyze your heart impulses by ECG. The digital platform with 1000 Hz, 24 bit ECG-technology delivers excellent high quality ECG.

You analyze your heart by heart simply holding the Coala for 30 seconds towards your chest, followed by using your thumbs for 30 seconds, also known as thumb-ECG. The double ECG recording maximizes quality, precision and accuracy. 

The Coala connects via Bluetooth to your smartphone and the Coala App. All the data is stored securely in the cloud. The Coala is delivered with a smart charging station and several accessories, designed to quickly and easily enable a heart screening when and wherever you want. 

No sticky electrodes, patches or separate pieces, it's all integrated. You're in charge as the user to use the Coala when you want.

 

Data access and interfaces developed to suit each user's needs. 

The analysis is performed in real-time in the cloud based on smart, validated algorithms. The user typically has its results within 5 seconds in the Coala App.

All data is at the same time available in the Coala Care portal. This web accessed portal is simply reached from a computer and provides an overview of each connected Coala users data and digital journal. The user is in charge and controls whom has the right access its dat

It's free to access the Coala Care portal, and if a caregiver wishes to access and review a Coala user, then a message is sent to the Coala App whereby the Coala user grants the caregiver access to review its data. It's quick and simple, and ideal for remote monitoring and with the ability to communicate directly with the Coala user through the system.

 

Capture clinical performance ECG and get real-time analysis of your heart.

The analytic algorithms used in the Coala are based on well-tested methodologies and a long experience with analysis of arrhythmias and atrial fibrillation signals.

Coala uses a cloud based system based on research presented in 40+ scientific journal papers, and used in tens of thousands of ECGs.

The core algorithms are developed and validated in a collaboration between Lund University and Karolinska University Hospital, Sweden. Coala Life has developed additional proprietary software to further enhance the use of the algorithms. 

The algorithms identify beats and groups them into beat classes with different morphologies. It analyses the beat sequence in detail providing markers for a wide range of events. The system performs robust interval measurements based on averaged beats, and it categorizes the signals or signal segment into one of twelve categories for efficient identification of important cases in large databases or important segments in long recordings.

 

A complete cardiac eco-system with the ability to connect any caregiver to the system.

As Coala Premium subscriber, the HeartCareLine™ (Hjärtupplysningen™) health care provider (only available in Sweden) is integrated and included in the fee. They are just a phone call away, and included in the subscription fee.

HeartCareLine™ has access to the Coala Care Portal and with the ability to review data in realtime and provide healthcare advice. 

Any caregiver can be connected to the system, provided they are listed with Coala Life. It's simple, free of charge and offer the ability to connect your personal MD, your cardiologist, perhaps your occupational health physician, or just any caregiver you want to remotely follow you heart. 

Follow you heart with Coala. For more info, contact us at info@coalalife.com

 

Quickly share PDF's and integrate into Electronic Health Records. 

The Coala Care portal provides caregivers with the easy ability to create PDF's of all the ECG recordings, as well as download the raw data. The PDF's are ideal for sharing, for archiving in EHR's and further analysis. 

The Coala Care portal can be easily accessed from any online computer or tablet.

 

Analysis based on smart algorithms to enable quick interpretation

The Coala Care portal provides caregivers with the ability to quickly interpret data. The cloud based system based on research presented in 40+ scientific journal papers, and used in tens of thousands of ECGs.

The core algorithms are developed and validated in a collaboration between Lund University and Karolinska University Hospital, Sweden. Coala Life has developed additional proprietary software to further enhance the use of the algorithms. 

The algorithms identify beats and groups them into beat classes with different morphologies. It analyses the beat sequence in detail providing markers for a wide range of events. The system performs robust interval measurements based on averaged beats, and it categorizes the signals or signal segment into one of twelve categories for efficient identification of important cases in large databases or important segments in long recordings.

 

Introducing the new Coala Pro

The Coala Pro (blue in color) is developed and offered to professional users to enable efficient, high performance yet simple arrhythmia assessments as well as diagnosing and managing patients with AFIB. Ideal to track EKG recordings and interpretations between patient visits.

The Coala Pro is sold to caregivers with unrestricted use, ability to perform multi-patient assessments and ideal for telemedicin applications. The Coala Pro is offered solely to professional users and sold via Coala Life AB and selected partners. It is not offered with the HeartCareLine™ (Hjärtupplysningen™) service which is targeted for the consumer offering only.

 

A smart subscription based service available for everyone, anywhere*. 

The Coala Heart Monitor is offered with different service plans. The Premium plan offers:

  • Unlimited recordings, use and analysis based on 11 different arrhythmia categories
  • Long term secure data storage of data in the cloud.
  • Direct connection to HeartCareLine™ (Hjärtupplysningen™) a health care provider (currently only available in Sweden). They're connected to the Coala and consists of specialty cardiac nurses ready to provide help is needed, or just an advice.
  • Ability to grant other caregivers access to your data through the Coala Care Portal.

The Basic plan is is more simple, and without the included service of HeartCareLine™.

*The Coala is currently only offered in Sweden, but can easily be adapted for other regions and licensed as a system.

 

A cloud based solution for your heart

All the data is analyzed in the cloud, and Coala has partnered with Microsoft and its Azure solution to enable intelligent, high-performance, real-time analysis and data access.

Your personal digital heart journal is always available in the cloud and accessed through your smart phone, or through the Coala Care portal by caregivers. 

Follow your heart by conducting frequent recordings. Annotate your results and comment in the app when needed. 

All Coala users have the option of sharing their heart history in the Coala Atlas. This is a secure, global database of ECG and heart sounds intended to offer researchers unique tools to ultimately help develop medications, products or methods for being able to win the global fight against heart disease.

 

 

Simply the solution for your everyday life. 

The Coala is developed to:

  1. Enable preventive and early detection of heart disease by smart, validated algorithms for real-time analysis and AFIB detection of the heart. 
  2. Alleviate worries related to the heart. Powered by an eco-system that can be connected to caregivers. The user in control, no sticky electrodes, no implants, just real-time analysis. 
  3. Help reduce the burden on healthcare by connecting caregivers for remote diagnostics, follow-up and reducing the need of physical appointments.

Follow your heart with the Coala.

For more info, contact us at info@coalalife.com

 

Milestones 1821 - 2017

• 1821 The analogue stethoscope is invented by the French physician Rene Laennec. Today, there are over 25 million units on the market.

• 1900 The Dutch physiologist Willem Einthoven develops the first real equipment for recording ECG signals. A solution that weighed approximately 270 kg and required five people to conduct the examination.

• 1991 A key publication included in the comprehensive Framingham study, confirms that atrial fibrillation increases the risk of stroke considerably.

• 2001 The European Society for Cardiology (ESC) and the American Heart Association (AHA) publish the first, joint, international guidelines that recommend ECG monitoring to detect and diagnose atrial fibrillation.

• 2004 Coala Life is founded by Swedish entrepreneurs and physicians with the goal of developing wireless systems for digital monitoring and diagnosing of the heart.
• 2007 The first generation Coala technology platform is developed and the first patent is approved.

• 2013 Coala Life reaches a technological breakthrough. The fourth generation's new digital technology platform provides a completely new way of screening patients by digitizing heart sounds, simultaneously taking an ECG on the chest and analysing the data in the cloud.

• 2015 Major Swedish studies confirm that preventative ECG screening leads to both earlier and more frequent detection of atrial fibrillation.

• 2015 The fourth generation technology platform and analysis algorithms are successfully verified. Coala is developed into a unique, medical technology system that allows users to monitor their heart any time, any place and very easily. An innovative and true e-health service in collaboration with caregivers. Coala Atlas is created. Coala Life is awarded additional patents.

• 2016 Coala Life collaborates with industry leaders such as Microsoft, Ericsson, Sigma and Stockholm Heart Center in preparation for the upcoming market launch. Coala is CE-approved and Coala Life is ISO 13485 certified. LloydsPharmacy signs agreement to retail the Coala in Sweden.

• 2017 The Coala is launched in Sweden and sold online and in retail by LloydsPharmacy in Sweden. Consumers buy the Coala and subscribe for the service, and many Swedish health care providers access the data in the Coala Care Portal. Hjärtupplysningen (HeartCareLine) is established in Sweden as the first integrated care provider offering cardiac consultation based on the Coala for Premium subscribers. 

• 2017 Q1 Coala Life is honored as a finalist in the Swedish Mobile Awards 2017 and is a proud winner and part of "Sweden’s 33 hottest tech companies list 2017". 

• 2017 Q2 Launch of the Coala Pro, a unique digital solution for caregivers and professional users to enable efficient, high performance yet simple arrhythmia assessments as well as diagnosing and managing patients with AFIB. Coala Life wins the prestigious eHealthAward 2017, handed over by the Swedish Minister of Health.

hjärtsjukdom ekg Coala Heart monitor

About us

"We believe in a world where mankind is digitized, connected and screened for early detection and disease prevention."

Coala Life is a Swedish medical technology and life science company focusing on heart diagnostics and mobile health. The company has developed the Coala Heart Monitor, a patented and commercial solution for remote monitoring and self-screening of heart sounds and ECG. We make it possible for everyone to monitor their heart.

Cardiovascular diseases are one of the leading causes of death around the world. A key contributor is late diagnosis. Coala Life was founded in 2004 by physicians and Swedish entrepreneurs to change that. Now the solution is here that replaces an analogue device from the 18th century, the stethoscope, with a digital solution that records both heart sounds, ECG, and heart rate. A unique solution that listens, measures and analyses heart data, which allows many heart diseases to be detected and treated early, including atrial fibrillation, which increases the risk of stroke significantly. A series of patents and unique technology is the base this unique Swedish system. Coala makes it possible for everyone to screen and monitor their heart, in close contact with physicians and cardiologists.

Coala Life Coala Heart Monitor team

 

THE TEAM

Philip Siberg Co-founder and CEO, Johanna Tulkki COO, Magnus Samuelsson CTO, Lovisa Fasth Digital Content Manager, Titti Lundgren CMO

Philip has founded, built, globally expanded and sold a number of medical device companies, both venture funded and publicly traded. Johanna and Magnus bring in successful careers from the cardiac diagnostics company Radi Medical and later St. Jude Medical, the global leader in solutions fr the heart. Titti is the marketing super woman with a career as CEO and CMO in a number of medical and consumer oriented companies. Lovisa joined us as the digital expert with studies and work in New York. 

THE BOARD

Ulf Tossman Co-founder, Executive Chairman and Medical Director, Sören Olofsson, Anders Qvarnström, Anders Nyrén, Peter Risberg, Anders Rodebjer and Jan Flood.

Ulf has a PhD in Medical Science and with many years of experience as Medical Director, investor and business developer in the Life science field. Sören has among many things been the CEO of some of Swedens largest hospitals and advised the European Union in e-health. Anders Q has vast management experience from the medical device industry, including been the CEO of St. Jude Medical in Sweden. Anders N has a honorary PhD in economics and is one of Sweden's most prominent industrialists, he just left as Board Member of Ericsson. Peter is a helping to organize and build the new Karolinska Hospital and has previously been the CEO of Previa, the largest occupational health company in Sweden. Anders R has medical degree and is the super corporate finance guy. Jan is a lawyer and one of the founding investors of the company. 

THE SUPPORTERS

The Coala investors include some of Swedens most prominent doctors, professors, entrepreneurs, life science experts, business angels, institutional investors, family offices, the management team and just ordinary people sharing our mission and vision. Thank you. 

The Coala Heart Monitor

The Coala Heart Monitor


Heart Diseases

One of the greatest health problems of our time

Cardiovascular diseases are some of the most common causes of death in the world. More people die from cardiovascular diseases then from AIDS and all forms of cancer combined. In Sweden, four out of ten Swedes die of heart diseases. Many heart diseases can be detected and appropriately treated through preventive screening and diagnostics, including auscultation (listening to the heart) and ECG. 

Atrial fibrillation, the silent killer

Atrial fibrillation (AFIB) is one of the most prevalent cardiovascular diseases. More than 30 million people are affected, which makes the disease one of the most common forms of heart disease in the world. In Sweden alone, more than 300,000 people are affected.

The problem is that many people do not know that they have a heart disease. If proper treatment is not provided, the risk of dying prematurely is twice as high. A person with AFIB runs five times the risk of suffering a stroke and three times the risk of heart failure. In addition, the risk increases with age. One of four people over the age of 40 are at risk of suffering from AFIB.

Among people over 75 years of age, AFIB can be considered a public health disease. Examining and detecting the symptoms early is key to avoiding more serious consequences. AFIB is detected using an ECG and typically treated with medication and cardioversion.

AFIB is detected most easily with an ECG, but since the fibrillation can occur irregularly, regular screening is often preferred. However this requires access to ECG equipment that can be carried or used regularly over a longer period of time. According to the recommendations from the Swedish Board of Health and Welfare (2015), caregivers should offer treatment by using blood thinning medications for all forms of atrial fibrillation. The estimate is that this will prevent 27,000 cases of stroke over the next 20 years. A further estimate is that 30,000 new individuals will be diagnosed with atrial fibrillation each year. In Sweden less than 50% of the patients with atrial fibrillation currently receive treatment using blood clot inhibitors. Lack of treatment is particularly common in terms of women and people over 80 years of age.

Cost simulations (Davidson et al) indicate that with the new blood-thinning medications, Swedish helathcare costs will increase (SEK 158 million over 20 years), while society saves large resources (SEK 3.352 billion), primarily through reduced costs of stroke care.

The assumption is that more widespread screening, and therefore more efficient diagnosis, can prevent approximately 27,000 cases of stroke, which will result in 57,000 additional years of life, with improved lifequality. The Swedish Dental and Pharmaceutical Benefits Agency (TLV) has completed an analysis of the costs of performing mobile screening from a lifespan perspective and the conclusion is that the cost is low.

In a study published in the European Journal of Health Economics 2011, the total costs for atrial fibrillation in Swedish society is estimated at SEK 6.6 billion in 2007. Of this total, SEK 5.8 billion is related to direct costs such as hospitalizations, transportation, doctors visits, pharmaceuticals and the treatment of complications. A large part of the cost comes from serious, subsequent diseases caused by atrial fibrillation.

 

National screening is expected to lead to both earlier and more detection of atrial fibrillation.

In June 2015 The Swedish National Board of Health and Welfare was commissioned by the government to investigate and implement a national screening program for atrial fibrillation. The study was conducted in collaboration with the Swedish Council on Medical and Social Assessment (SBU) and the Dental and Pharmaceutical Benefits Agency (TLV).The final report is to be be submitted to the Swedish government (Ministry of Health and Social Welfare) by 2017.

More efficient care processes are needed

A common problem for patients with atrial fibrillation is that they are at risk of facing long queues for care when they are looking for help at a hospital and may not always get the expert help they need. Many times, patients with atrial fibrillation are just treated for their temporary discomfort. An electrical conversion is performed, which briefly means that the patient receives an electric shock to restore balance to the heart rate, however there is a risk of delaying the decision of the actual problem and not creating a long-term treatment plan.

These poor treatment processes can affect both patients as well as society. The fact that many people are forced to drive to and from the hospital while fibrillation attacks are occurring, is cumbersome for the individual and results in large socio-economic expenses. Over the past 20 years, in-patient care as a result of atrial fibrillation has increased by 60%, and the cost for atrial fibrillation will likely increase, due to the increasing percentage of elderly persons in the population.

ECG does not detect all heart diseases

The stethoscope is used by more than 15 million physicians each day to listen to the heart. It is an easy and quick way to conduct an initial, subjective examination of the patient. The physician looks for murmurs, a medical term for the sounds that can be heard when swirls are formed in the blood that streams through the heart. Murmurs in the heart may be normal in healthy people (so-called physiological murmurs), but they can also be caused by problems and diseases with the heart valves, so-called valvular heart diseases. Murmurs are

normally not visible on an ECG. Valvular heart diseases can be congenital or acquired. In Sweden, age-related calcification of the heart valves is the most common cause for valve problems. Valvular diseases can consist of constrictions (stenosis) or leakage (insufficiency) which means that the valve does not close properly.

Aortic stenosis (constriction of the aortic valve) is the most common valvular disease in the industrialized world. Roughly two percent of those over 65 years of age, and five percent of everyone over 80 years of age are affected. The disease is often detected in connection with the physician listening to the heart using a stethoscope.

Valvular diseases can also lead to congestive heart failure. It is the most common cause of hospitalization in Sweden, resulting in major expenses. Roughly 200,000 Swedes suffer from heart failure, and among people over 80 years of age, up to ten percent have symptoms of congestive heart failure.

Many patients today have a poor understanding of their disease, which results in increased hospital readmissions.. Through screening and more efficient methods in terms of primary care, there is the potential to determine at an early stage which patients will need to be sent for further examination. This can lead to an increased quality of life for the patient as well as a reduction in the treatment period, which leads to efficiency gains.


Philip Siberg
CEO
Philip.siberg@coalalife.com

Tel: +46 70 7906734

Lovisa Fasth
Digital Content Manager
lovisa.fasth@coalalife.com